Radiotherapy plus Trastuzumab have little effect on left ventricular ejection fraction in HER2+ breast cancer

A new study found that concurrent trastuzumab and radiotherapy at low doses does not have a significant effect on left ventricular ejection fraction changes in HER2-positive breast cancer patients. Changes to this measure of cardiac output were due more to doxorubicin treatment.
Cancer Network